ArticleFrontiers in oncology2022

3D CRISPR screen in prostate cancer cells reveals PARP inhibitor sensitization through TBL1XR1-SMC3 interaction.

Huan Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.